Tuesday, 30 June 2020

SAP FICO consultant | Pharmaceutical@ Fort Worth, Texas

-(Not for opt/cpt Visa holders)
Hi,
 
We are looking for SAP FICO consultant | Pharmaceutical@ Fort Worth, Texas. If you are interested kindly send your updated resume and rate you are looking for this position on C2C/W2 hour.
 
 
 
Job Title:  SAP FICO consultant | Pharmaceutical
Location: Fort Worth, Texas
Duration: 06 months+ extension possible
No. of Positions: 1
Position Type: C2C
Client:Infosys/ Novartis Pharma
 
Job Description:
* In the role of a Principal Consultant, you will anchor the engagement effort for assignments, all the way from business process consulting and problem definition to solution design, development and deployment.
* You will be pivotal to problem definition and discovery of the overall solution and guide teams on project processes, deliverables.
* As a thought leader in your domain, you will be the key advisor to architecture and design reviews.
* You will anchor business pursuit initiatives, client training, in-house capability building.
* You will have the opportunity to shape value-adding consulting solutions that enable our clients to meet the changing needs of the global landscape.
* At least 10 years of experience in SAP FICO with MM backgorund / R2P module along with any experience with Pharmaceutical Industry.
Must Have Skills:
At least 10 years of experience in SAP FICO with MM background / R2P module along with any experience with Pharmaceutical Industry.
 
Certifications Needed : NO
 
 
years of experience : 10+ years
 
Interview Process (Is face to face required?): NO
 
 
   

 
Thank you,
Best regards,
 
Sarat Chandra
O: +1 8183094741 or 8187910114| E: sarat@us.vedainfo.com 
Certified Women Owned Minority Business Enterprise {WMBE}
3868 Carson Street, Suite 204, Torrance, CA 90503 | Offices: USA, India, Australia

Vedainfo Inc, 23133 Hawthorne Blvd,, Suite B-01, Torrance, CA 90505
Sent by sarat@us.vedainfo.com in collaboration with
Constant Contact
Try email marketing for free today!

No comments:

Post a Comment